MD Revolution has announced a collaboration with Dexcom to incorporate continuous glucose monitoring (CGM) into its remote care management platform. Dexcom specialises in CGM technology, including its latest G7 system, which interfaces with smartphones and Apple Watches to monitor glucose levels in individuals with diabetes.
MD Revolution's platform integrates with various EHRs, data partners, and devices, facilitating comprehensive remote care for large healthcare practices and organisations. The partnership aims to provide clinicians with access to glucose monitoring data through the care management platform, empowering them to make informed decisions and better support patients.
According to MD Revolution co-founder Dr. Samir Damani, Dexcom's technology enables patients to closely manage their glucose levels, offering access to clinical health coaches and real-time remote care. This integration enhances the company's scalable care management platform, providing streamlined services for CGM patients within a cohesive remote care strategy.
CEO Kyle Williams emphasised that the partnership with Dexcom is beneficial for providers seeking remote care management for CGM patients, offering integrated services, billing, and management within a unified remote care approach.
Click here to read the original news story.